Rexahn Pharmaceuticals, Inc. to Present at the Stifel Nicolaus 2012 Healthcare Conference

Published: Aug 30, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced that it will present at the Stifel Nicolaus Healthcare Conference on September 5, 2012, at 9:10 AM Eastern Time at the Four Seasons Hotel in Boston, MA.

Back to news